Tom Ressemann

Tom Ressemann is the current President & CEO at EarliTec Diagnostics. Prior to this, they were with Zurex Pharma, University of Minnesota, and Children's Theatre Company. Tom has also been a Board of Director for Microbiologics and Entellus Medical, and was the Founder, President and CEO of Incubex, LLC. Their previous experience also includes Vice President of Sales and Marketing at Velocimed Products under Abbott.

Tom Ressemann has a Bachelors of Science in Mechanical Engineering from North Dakota State University. Tom also has a Masters of Business Administration from St. Cloud State University - Herberger Business School. Tom has certifications from Amherst H. Wilder Foundation in Intercultural Development Inventory and Plan and NACD (National Association of Corporate Directors) in Member. Their educational career focus is in Corporate Governance and they have studied at both The Wharton School and Stanford University.

Some individuals on their team include Ami Klin - Scientific Founder, Margaret Boiano - VP of Market Access & Health Economics, and Sreeni Narayanan - CTO.